Blind Freddy (let alone the one-eyed supporters amongst us)...

Blind Freddy (let alone the one-eyed supporters amongst us) could see from the last 4C that a
cash raise will be needed at some point. Early Q2 2023 still looks like the more likely time to me.
CR is very typical for all Co's with limited fundamental value support and heavily dependent on
near to mid-term speculative sentiment.

Getting the timing right on the next CR is very important. We don't know what we don't know....
but, management has far more knowledge on trial progress to date and where the SP will likely be
after the results announcement. They should also know to get the timing a whole lot better than
the last time we had a CR.

CR is part of life in the spec end of the market as it provides currency to continue with projects...
A CR next year after successful trial results and at an SP far higher than what we have today would
be very prudent and hard to argue against. Let us see!